While the nigericin-triggered NLRP3 activation in intermediate and classical monocytes was comparable to that of uninfected subjects, it was specifically increased in CD14dimCD16+ nonclassical monocytes, and inversely correlated with the decreased number of these cells in severe-to-critical COVID-19 patients. This evidence concerns the gene NLRP3 and COVID-19.